Synta Pharmaceuticals (SNTA) Misses Q1 Loss Views by 2c/Share
Tweet Send to a FriendGet Alerts SNTA Hot Sheet
Price: $3.95 -1.25%
Revenue Growth %: -100.0%
Financial Fact:
Total operating expenses: 20.26M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -100.0%
Financial Fact:
Total operating expenses: 20.26M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade SNTA Now!
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q1 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $100 thousand versus the consensus estimate of $660 thousand.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Synta Pharmaceuticals (SNTA) CEO Buys Another 10K Shares
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
- Adobe Systems, Inc. (ADBE) Tops Q2 EPS by 2c; Issues Q3 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
